Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06497231

Evaluation of Bioactive Giomer Material Versus Nanohybrid Resin Composite in Deep Marginal Elevation

This study will be conducted to evaluate the clinical, radiographic and periodontal performance of bioactive Giomer compared to nanohybrid resin composite restoration in deep subgingival proximal cavities extending below the CEJ over a period of 24 months.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Background and rationale:

Recent development in different adhesive techniques and materials has led clinicians to attempt restoring teeth with subgingival defects below the cemento-enamel junction (CEJ). Deep marginal elevation (DME) or cervical margin relocation (CMR) is a procedure that involves raising the proximal margin of the tooth defect with direct composite to promote isolation and restoration using direct, semi-direct or indirect techniques. A high level of knowledge and clinical expertise are necessary to perform such procedure in a predictable way in addition to meticulous attention to the supracrestal tissue attachment or the biological width which consists of junctional epithelium and supracrestal connective tissue attachment.

Research question:

In young and middle-aged patients having deep subgingival proximal cavities extending below CEJ, will the bioactive Giomer show similar clinical, radiographic and periodontal performance compared to nanohybrid resin composite over 2 years follow up?

Statement of the problem:

Carious lesions that extend in subgingival areas present several difficulties for the clinician. Firstly, applying rubber dam in deep cavities and the process of trying to obtain a gingival margin free of caries are very challenging. Secondly, there is a great biological concern to master the subgingival restoration reaction with the adjacent periodontal tissues. Obtaining a healthy periodontal status after treatment has long been a challenging endeavor in the restorative dentistry. Lastly, bonding to deep, carious, and moist dentin surrounded by cementum is inherently suboptimal. To overcome these problems, many techniques and materials were presented to deal with such complex restorative situations. Because of their chemical adherence to the tooth structure, fluoride release and hydrophilicity glass ionomer cements are a reliable option for cementum margins and deep dentin bonding. Marginal defects appearing at the cervical margins due to the solubility property of the material was the main problem the dentist faced in these situations. On the other hand, resin composites are a dependable choice in these circumstances due to their higher mechanical qualities and the way their composition has improved, however, poor material bonding in subgingival margins along with high polymerization stresses associated with them have made it a very complicated procedure.

Rationale for conducting the research:

The use of fluoride releasing dental materials in deep carious lesions was explored before to remineralize the surrounding tooth structure and allow for a more durable restoration with increased resistance to the development of secondary caries. The introduction of Giomers, which combines resin composite and glass ionomer modes of action by Shofu, (Inc.) in the early 2000s was due to the revolutionary surface prereacted glass-ionomer (S-PRG) filler technology that allowed for improved resistance to recurrent caries development. Therefore, this type of bioactive system, adhesive and restoring materials, was claimed to enhance the outcome of deep subgingival restoration clinically, periodontally, and radiographically.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Young and middle aged patients (20-50)
  • Good or moderate oral hygiene (plaque index 0 or 1 )
  • Patient approval
  • Absence of parafunctional habits and/or bruxism

Exclusion criteria

  • Patients with known allergic or adverse reaction to the tested materials.
  • Systematic disease that may affect participation.
  • Xerostomic patients.
  • Patients with active periodontal disease.
  • Heavy smokers

Treatment and study plan

Beautifil II LS

Other

Beautifil II LS is a low shrinkage bioactive giomer resin composite.

Nanohybrid resin composite material

Other

Nanohybrid resin composite is a type of restorative material that features nano-sized fillers as a main component.

Primary outcomes

  1. Post-operative sensitivity

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    Restorations will be assessed by testing of irritability of the pulpal nerve on cold, e.g., with dry ice or cold spray, in comparison to the reaction of a contralateral, sound, and unrestored tooth.

Secondary outcomes

  1. Marginal adaptation

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    Method of restorations assessment will be Tactile using different sized explorers. Assessment will be done using FDI criteria and recorded as scores from 1 to 5, where scores from 1 to 5 will indicate clinically excellent/very good, clinically good, clinically satisfactory, clinically unsatisfactory and clinically poor respectively.

  2. Occurrence of caries

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    Method of restorations assessment will be Tactile using different sized explorers. Assessment will be done using FDI criteria and recorded as scores from 1 to 5, where scores from 1 to 5 will indicate clinically excellent/very good, clinically good, clinically satisfactory, clinically unsatisfactory and clinically poor respectively.

  3. Proximal Contact

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    Method of restorations assessment will be tactile using unwaxed dental floss to evaluate proximal contact tightness. Assessment will be done using FDI criteria and recorded as scores from 1 to 5, where scores from 1 to 5 will indicate clinically excellent/very good, clinically good, clinically satisfactory, clinically unsatisfactory and clinically poor respectively.

  4. Plaque Index

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    The Plaque Index (PI) is a clinical tool used by dentists to assess the presence and severity of dental plaque accumulation on the teeth. It is scored on a scale of 0 to 3:

    0: No plaque present.

    • A thin film of plaque visible only with a probe or at the gingival margin.
    • Moderate plaque accumulation visible to the naked eye.
    • Heavy plaque accumulation visible on the tooth surface.
  5. Gingival Index

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    The Gingival Index (GI) is a clinical tool used to assess the health of the gums by evaluating the presence and severity of gingival inflammation.

    Gingival Index Scoring (0 to 3):

    The Gingival Index evaluates the gingiva (gums) at four sites per tooth (mesial, distal, buccal, and lingual). Each site is scored on a scale from 0 to 3:

    0: Normal gingiva - No inflammation, healthy gums.

    • Mild inflammation - Slight redness, no bleeding on probing, no swelling.
    • Moderate inflammation - Redness, slight swelling, and bleeding on probing.
    • Severe inflammation - Redness, swelling, and bleeding even without probing; possibly ulcerated or visibly infected gums.
  6. Interdental Pressure Index

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    Apical pressure of a horizontally placed periodontal probe is applied to evaluate periodontal tissue response. It is negative when gingival tissues are firm, bleeding-free, and slightly ischemic by the stimulation; otherwise it is positive.

    It follows a negative or positive binary score.

  7. Papillary bleeding on probing Index

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

    The Papillary Bleeding on Probing (PBI) Index is a clinical tool used to assess the presence of bleeding from the papillary gingiva (the area of gum tissue between the teeth) when a periodontal probe is gently inserted. This index helps evaluate the level of gingival inflammation and is commonly used in diagnosing gingivitis or early stages of periodontal disease.

    Scoring System: The PBI uses a simple scale to score bleeding, often as follows:

    0: No bleeding on probing - Healthy gingiva with no signs of inflammation.

    • Bleeding on probing - A slight amount of bleeding from the papillary gingiva occurs within 15 seconds after probing.
    • Bleeding on probing with immediate response - Bleeding is visible immediately after probing, indicating more significant inflammation.
    • Spontaneous bleeding - Bleeding occurs without probing, indicating advanced gingival inflammation or active gum disease.
  8. Probing Depth

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

  9. Radiographic examination

    Time frame: Baseline (1 week after intervention), 6 months, 12 months and 24 months

Study contacts

Contact information is provided by the study sponsor or research team.

Samir Ashraf, BDS

CONTACT

[email protected]

01020726828

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Clinical and Periodontal Evaluation of Deep Marginal Elevation for Proximal Carious Lesions Restored with Bioactive Giomer Versus Nanohybrid Resin Composite: Two Years Randomized Trial

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Jul 11, 2024
Registry last updated
Nov 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.